How DMEPOS Facility Accreditation Rankings Affect Your Medicare Reimbursement

For suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS), accreditation is more than a compliance checkbox. It is a direct precondition for Medicare billing privileges. In recent years, the conversation among suppliers has shifted from simply holding accreditation to understanding how accreditation performance—and perceived ranking—can influence audit exposure, supplier standards, and ultimately the speed and reliability of reimbursement.

Recent Trends in Accreditation Oversight

CMS has steadily strengthened the link between accreditation status and reimbursement integrity. Recent trends suggest a move toward more data-driven oversight, where accreditation bodies are expected to report not just pass/fail outcomes but more granular performance metrics. Suppliers are increasingly seeing:

• More frequent unannounced site visits, particularly for high-risk product categories such as power wheelchairs and complex rehab technology.
• Greater emphasis on face-to-face documentation and medical necessity records during accreditation surveys.
• Renewed scrutiny of supplier number activism, where accreditation lapses are cross-checked against active billing activity.
• An uptick in post-accreditation spot checks, meaning a favorable initial survey does not guarantee uninterrupted reimbursement.

Background: How Accreditation Fits Into Medicare Billing

Under the Social Security Act, DMEPOS suppliers must meet federal quality standards and obtain accreditation from a CMS-approved accrediting organization before they can bill Medicare. Accreditation itself is not a rating system in the consumer sense—CMS does not publish a national leaderboard of suppliers—but the term “ranking” has entered common usage to describe comparative performance among suppliers and accrediting bodies.

In practice, what functions as a ranking is the combination of accreditation results, claim denial rates, and prior audit history. Suppliers with clean accreditation surveys and low claim rejection rates are effectively ranked higher by Medicare administrative contractors, which can result in fewer prepayment reviews and faster claim processing. Conversely, suppliers with repeated deficiencies may be placed on payment suspensions or referred to law enforcement.

User Concerns: What Suppliers Are Asking

Suppliers frequently express uncertainty about how accreditation performance affects day-to-day cash flow. The most common concerns include:

• Whether a mid-cycle accreditation change resets audit risk. Switching accrediting organizations does not reset compliance history, so past deficiencies may still influence future reimbursement reviews.
• How survey findings affect claim hold patterns. A significant finding during a survey can trigger targeted claim review, even if the supplier remains accredited.
• Whether higher accreditation fees buy faster reimbursement. Fees vary by accrediting organization, but higher cost does not correspond to faster Medicare payment. Payment speed is governed by claims processing, not accreditation prestige.
• How to interpret corrective action plans. A corrective action plan that is not completed within the accreditor’s timeframe can lead to revocation of accreditation and immediate loss of billing privileges.

Likely Impact on Your Reimbursement

The practical effect of accreditation rankings is felt most acutely in three reimbursement areas:

• Claims review selection. Suppliers with a history of deficiency-free surveys are less likely to be selected for medical review, reducing the administrative burden of submitting additional documentation.
• Reimbursement stability. A supplier that loses accreditation cannot bill Medicare, creating a total revenue interruption until re-accreditation is obtained—a process that may take several months.
• Contracting leverage. Some state Medicaid programs and commercial payers align their enrollment requirements with Medicare accreditation status, so a lapse can affect reimbursement beyond traditional Medicare.

Suppliers should view accreditation not as a one-time event but as a continuous condition of payment. A full survey cycle typically runs three years, but documentation standards apply to every claim submitted during that period.

What to Watch Next

Several developments are worth monitoring as the accreditation landscape evolves:

• Potential CMS updates to supplier standards. If CMS revises the quality standards, accrediting organizations will likely adjust their survey tools, which could affect the frequency and strictness of surveys.
• Consolidation among accrediting organizations. Market changes could alter the available options for suppliers, with potential differences in survey rigor and pricing.
• Greater use of claims data in accreditation surveillance. As data sharing improves, accreditors may begin using billing patterns to identify suppliers for early intervention, effectively creating a real-time performance ranking.
• State-level policy shifts. Some states are exploring separate licensure or enrollment requirements for DMEPOS suppliers, which could layer additional compliance burdens on top of accreditation.

For now, the most reliable strategy is straightforward: maintain clean documentation, treat every survey as a high-stakes review, and assume that accreditation status will continue to function as a gatekeeper for reimbursement. Suppliers who internalize that expectation are better positioned to avoid claim denials and keep revenue flowing steadily.